Figure S1 from The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity

2026 Open access

Read full text
Authors: Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, Martyna C. Popis, Magdalena Niedzielska, Bishnu P. Joshi, Reed Masakayan, Gerard Rubi-Sans, Stephen Addis, Justin G. Keith, Shanmugarajan Krishnan, Jin San Choi
+27 more Stephanie Sanders, Alvaro Sebastian-Yague, Shannon Kathryn Boi, Moira Pinzan-Rossi, Georgios Antonopoulos, Paul Ibbett, Deborah E. Wright, Olivier Le Tonquèze, Nick Kushner, Chinar Pathak, Kah Teong Soh, Amy L. Chalmers, Rachel Smith, Vignesh Venkatraman, Sara Farahi, John Pravin, Priyadarshini Iyer, Emmanuel Briend, Olga Ignatovich, Marco A. Purbhoo, Tyler Jay Curiel, Mark Adrian Exley, Robert Benjamin Stein, Enoch Kim, Jennifer S. Buell, Marc A. van Dijk, Dhan Sidhartha Chand
DOI: 10.1158/2326-6066.31239179
Cited by: 0

Abstract

Distinct FAP-CAR constructs target non-overlapping epitopes on FAP protein

Fields of Study & Subjects

CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Publication date
3 February 2026